Mar 6, 2023 06:01AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
May 12, 2022 06:45AM
May 12, 2022 06:45AM
Mar 22, 2022 06:45AM TCR² Therapeutics Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update
Mar 22, 2022 06:45AM
Jan 10, 2022 06:47AM
Jan 10, 2022 06:45AM
Jan 10, 2022 06:45AM
Sep 2, 2021 09:26AM
Sep 2, 2021 09:19AM
Sep 2, 2021 09:19AM TCR² Therapeutics Receives FDA Orphan Drug Designation for Gavo-cel for the Treatment of Cholangiocarcinoma
Dec 29, 2020 07:42AM
Jul 27, 2020 09:30AM
Jul 27, 2020 08:39AM
Jul 26, 2020 05:00PM
Jul 26, 2020 05:00PM
May 27, 2020 08:00AM
May 27, 2020 08:00AM TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic Objectives
May 14, 2020 06:45AM
May 14, 2020 06:45AM
Apr 15, 2020 06:52AM
Apr 15, 2020 06:45AM
Apr 15, 2020 06:45AM
May 13, 2019 04:05PM
May 13, 2019 04:05PM TCR2 Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Apr 1, 2019 07:00AM
Feb 27, 2019 10:13AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All